Wells Fargo & Company cut shares of General Dynamics (NYSE:GD – Free Report) from an overweight rating to an equal weight rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $317.00 target price on the aerospace company’s stock, down from their previous target price of $334.00. Other research analysts […]

StockNews.com started coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report released on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. RVNC has been the topic of a number of other reports. Needham & Company LLC lowered Revance Therapeutics from a moderate buy rating to a […]

Pivotal Research started coverage on shares of Alphabet (NASDAQ:GOOG – Free Report) in a research report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $215.00 price target on the information services provider’s stock. GOOG has been the topic of several other research reports. Wolfe Research upgraded Alphabet to a strong-buy […]

Oppenheimer began coverage on shares of Jack Henry & Associates (NASDAQ:JKHY – Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued an outperform rating and a $206.00 target price on the technology company’s stock. JKHY has been the subject of several other research reports. Evercore ISI boosted their price objective […]

The Goldman Sachs Group upgraded shares of Ford Motor (NYSE:F – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday, Marketbeat Ratings reports. The Goldman Sachs Group currently has $13.00 price objective on the auto manufacturer’s stock, up from their previous price objective of $12.00. F has […]

Cantor Fitzgerald restated their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $7.00 price objective on the stock. Other research analysts also recently issued research reports about the stock. Robert W. Baird began coverage on shares of […]

Cantor Fitzgerald restated their neutral rating on shares of Lucid Group (NASDAQ:LCID – Free Report) in a research report released on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a $4.00 target price on the stock. Other research analysts also recently issued research reports about the stock. Robert W. Baird restated a neutral rating and […]

Piper Sandler reissued their overweight rating on shares of Alphabet (NASDAQ:GOOGL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Piper Sandler currently has a $200.00 target price on the information services provider’s stock. Several other research analysts also recently commented on the company. JMP Securities reissued a market […]

Cantor Fitzgerald reaffirmed their neutral rating on shares of Alphabet (NASDAQ:GOOGL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a $190.00 price target on the information services provider’s stock. Other equities research analysts have also recently issued reports about the stock. Rosenblatt Securities reaffirmed […]

BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) had its price objective increased by research analysts at Guggenheim from $15.00 to $18.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s price objective would suggest a potential upside of 21.54% from the company’s previous close. […]

Lam Research (NASDAQ:LRCX – Free Report) had its price objective lowered by Cantor Fitzgerald from $120.00 to $100.00 in a report released on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a neutral rating on the semiconductor company’s stock. A number of other analysts also recently commented on LRCX. Morgan Stanley dropped their price objective […]

Cantor Fitzgerald restated their neutral rating on shares of Lucid Group (NASDAQ:LCID – Free Report) in a report published on Monday, Benzinga reports. Cantor Fitzgerald currently has a $4.00 price target on the stock. Several other brokerages also recently commented on LCID. Robert W. Baird restated a neutral rating and set a $3.00 price objective […]

Wells Fargo & Company restated their equal weight rating on shares of W. P. Carey (NYSE:WPC – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $63.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $62.00. WPC has been the subject […]